Skip to content
Recall Observatory FDA recall evidence

Drug product

MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89

D-1686-2019

June 19, 2019

Class II

Product summary

Firm
RXQ Compounding LLC
Event
Event 83074
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1686-2019

Official wording

Reason: Lack of Assurance of Sterility

Code information: All lots within expiry

Distribution pattern: Nationwide USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility